Accelerating Cures: Debating Speed vs. Safety
Abstract
This article explores both sides of the controversial debate between speed versus safety in bringing new medicines to market for patients with rare diseases.
ISPOR recommends that you update your browser for more security, speed and the best experience on ispor.org. Update my browser now